{"nct_id":"NCT05364073","title":"Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2022-06-30","start_date_type":"ACTUAL","primary_completion_date":"2025-06-03","primary_completion_date_type":"ACTUAL","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AVBP"]}